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Abstract
Background: Alcohol is a significant component of the diet with dose-dependent risks and benefits. High doses of
alcohol damage the liver and early symptoms of liver disease include changes in routinely assessed liver enzymes.
Less is known regarding the mechanisms responsible for the benefits of moderate alcohol consumption, including
their effects on the liver. The objectives of this study were to examine alcohol’s dose-dependent effects on markers
of liver function (alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST),
gamma glutamyl transferase (GGT), and bilirubin), as well as to compare the different methods of assessing alcohol
intake using NHANES 2001–2010 adult data (N = 24,807).
Methods: Three methods were used to estimate alcohol intake from all volunteers: 24-h recall; the National Cancer
Institute (NCI) method of usual intake; and a specific alcohol intake questionnaire.
Results: Mean alcohol intake by 24-h recall, NCI method and questionnaire was 41.0 ± 0.8 g/d, 10.9 ± 0.2 g/d and
11.0 ± 0.2 g/d, respectively. Alcohol consumers had significantly lower levels of ALP and higher levels of AST, GGT
and bilirubin compared to non-consumers (P < 0.01) and activities of ALT, AST, and GGT increased and of ALP
decreased as alcohol intake increased, regardless of intake assessment method used. The most sensitive measure of
alcohol consumption was GGT.
Conclusions: Since alcohol had a graded linear effect on several liver enzymes, including at low and moderate
doses, benefits as well as risks of alcohol intake may be related to liver function. Since the NCI method and alcohol
questionnaire yielded very similar alcohol intake estimates, this study cross-validated these methods and
demonstrated the robustness of the NCI method for estimating intake of irregularly consumed foods.
Keywords: Alkaline phosphatase, Alanine aminotransferase, Aspartate aminotransferase, Gamma glutamyl
transferase, Bilirubin, NCI method
Introduction
Alcohol is consumed by about 70 % of U.S. adults [1].
Consumption of this dietary component has both risks
and benefits. Low to moderate doses of alcohol lower
the risk of cardiovascular disease and all-cause mortality
[2]. The Dietary Guidelines for Americans 2010 and
American Heart Association’s dietary guidelines suggest
that if alcohol is consumed, males consume no more
than two alcoholic drinks per/day (28 g/day) and women
no more than one per/day (14 g/day) [2, 3]. However,
approximately 38 million adults in the United States re-
port binge drinking an average of four times per month
and consuming an average of eight drinks per episode
[4]. Excessive alcohol intake was responsible for approxi-
mately 10 % of deaths among working age adults in the
United States during 2006–2010 [5] and cost the United
States $223.5 billion in 2006 [6]. It is estimated to be the
fourth leading preventable cause of death in the United
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States [7]. Heavy drinking, including binge drinking, in-
creases the risk of liver disease, hypertension, stroke,
type II diabetes, gastrointestinal cancers, injuries and
violence [2]. Alcohol abuse is the leading cause of liver-
related morbidity and mortality [8]. In alcoholic patients
increased levels of several liver-derived biomarkers are
associated with excessive ethanol intake and alcoholic
liver disease, and a number of studies have reported
induction of liver enzyme function due to excessive alco-
hol consumption [9–17]. However, only a few small
studies have investigated the effects of moderate alcohol
consumption on liver enzymes [12, 13].
The National Health and Nutrition Examination Sur-
vey (NHANES), a large nationally representative survey
of the U.S. population, is designed to monitor the health
and nutritional status of adults and children [18]. The
NHANES data are currently released every 2 years with
data from approximately 5000 adult volunteers and in-
clude an in-home survey and physical examination con-
ducted in a mobile facility. Food consumption, body
composition, health status, multiple blood chemistry
measures, and various other health-related parameters
are assessed. Because the NHANES is conducted regu-
larly using the same standardized procedures, very large
data sets can be obtained by combining multiple years of
data. This provides an opportunity to examine, in a large
nationally-representative data set, self-reported alcohol
use and its association with various markers of liver
function. In addition, the NHANES employs two
methods that can be used to independently estimate al-
cohol, collection of two days of 24-h recall data which
then can be used to estimate usual intake and an alcohol
intake questionnaire.
The primary objective of this study was to examine
the effects of graded levels of alcohol intake on markers
of liver function using the very large, nationally repre-
sentative, NHANES data set. We also compared several
methods for assessing alcohol intake: 1) single 24-h
recall; 2) usual alcohol intake based on the two 24-h
recalls collected by NHANES and adjusted using the
National Cancer Institute (NCI) usual intake procedure;
and 3) an alcohol consumption questionnaire.
Methods
Study population
NHANES data are collected by the National Center for
Health Statistics (NCHS) of the Center for Disease Con-
trol and Prevention (CDC) on a nationally representative
sample of non-institutionalized Americans [18]. All partic-
ipants or proxies provided written informed consent and
the Research Ethics Review Board at the NCHS approved
the survey protocol. Data from NHANES 2001–2002,
2003–2004, 2005–2006, 2007–2008 and 2009–2010 were
combined for the analysis. The combined sample included
24,807 adults age 19 years and older (12,561 males and
12,246 females) and excluded pregnant or lactating fe-
males, those with incomplete dietary records or missing
liver enzyme data. Response rates for NHANES are typic-
ally quite good, but they are related to age; for ex-
ample medical examination response rated typically
exceed 80 % for persons under age 20 but tend to be
less than 70 % for those age 70 or more [19].
Estimates of alcohol intake
Alcohol intake (g/day) was assessed three ways: 1) using
a single 24-h recall, an estimate of an individual’s self-
reported alcohol consumption on the day of recall; 2) by
determining usual alcohol intakes with the NCI method,
an estimate of long-term intake that employed data from
2 days of 24-h recalls; and 3) via an alcohol intake ques-
tionnaire quantifying annual consumption of alcohol.
Participants completed an in-person 24-h dietary recall
and health examination in a Mobile Examination Center
and a second 24-h dietary recall was collected via tele-
phone 3–10 day after the first recall using the United
States Department of Agriculture’s automated multiple-
pass method. A detailed description of the survey design
and the data collection procedures are available else-
where [18]. The usual intake analysis used the NCI
method with a two part correlated model in which the
probability of non-zero intake on a given day and the
usual intake on consumption days were estimated and
assumed to be correlated [20]. The two-part correlated
model was used since unlike nutrient intake, alcohol is
not consumed on most days by most people. The MIX-
TRAN and INDIVNT macros were used to estimate in-
dividual usual intakes with a recall day and weekday/
weekend (Friday-Sunday) intake indicator in the model.
Additionally, since an alcohol questionnaire was adminis-
tered during the NHANES household interview it was also
used to assess alcohol intake as average number of drinks
per day over the last year [18]. The alcohol content of
alcoholic drinks is defined as 12 oz of beer, 5 oz of wine or
1.5 oz of liquor and equals 14 g of alcohol [8, 21].
Outcome variables for markers of liver function
As part of the NHANES in-person health examination
in the Mobile Examination Center, participants provided
a blood specimen for laboratory analyses. Fasting prior
to collection of the blood sample was not required. The
activities of alkaline phosphatase (ALP), alanine amino-
transferase (ALT), aspartate aminotransferase (AST) and
gamma glutamyl transferase (GGT) were measured
spectrophotometerically in U/L units using their respect-
ive kinetic enzymatic methods, and bilirubin levels in
mg/dl were measured spectrophotometerically using a
timed-endpoint Diazo method [18]. ALT and AST are
aminotransferases that, when elevated, are indicative of
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reduced hepatocyte integrity. GGT and bilirubin are
markers of cholestasis [18, 22–24] and elevated levels
of bilirubin are associated with hemolytic jaundice
[18, 22–24].
Statistical analysis
Analyses were conducted using SAS 9.2 (SAS Institute,
Inc.; Cary, NC) and SUDAAN release 11.0 (Research
Triangle Institute, Research Triangle Park, NC). Appropri-
ate weighting factors were used to adjust for oversampling
of selected groups, non-response to the survey by some
individuals, and day of the week when the interview was
conducted. For each alcohol assessment approach, sub-
jects were grouped into deciles of intake as well as one of
seven alcohol consumption groups in g/d: 0, 0 to ≤7, >7 to
≤14, >14 to ≤21, >21 to ≤28, >28 to ≤35, and >35 (the
usual intake method did not have a 0 g/d group). These
levels are approximately equivalent to 0, 0 to ≤0.5, >0.5 to
≤1.0, >1.0 to ≤1.5, >1.5 to ≤2.0, >2.0 to ≤2.5 and >2.5
drinks/d, respectively. Least square (LS) means and stand-
ard errors (SE) of enzyme activities were determined using
PROC REGRESS of SUDAAN after adjustment for vari-
ous covariates. Outcome variables were adjusted for race-
ethnicity, age, physical activity (categorized as sedentary,
moderate, or vigorous based on responses to questions on
activity), poverty income ratio, smoking habits (yes/no),
energy intake, and BMI. Laboratory test values for ALP,
ALT, AST, GGT, and bilirubin were compared across dec-
iles of alcohol intake as well as alcohol intake levels in g/
day and effects of alcohol intake on liver enzymes were
assessed to ascertain whether an increase in alcohol intake
was associated with changes in enzyme activities and
whether changes were linear or curvilinear as a function
of alcohol. We used the Dunnett significant difference
post-hoc test (DUNNETT test option within PROC GLM)
to compare each category of alcohol intake to the non/low
alcohol consumer group. These post-hoc tests were sam-
ple weighted but not adjusted for the complex sample
design of NHANES as this capability was not available.
While not the primary focus of this research, we did
examine the impact of age, gender, socioeconomic status
(measured as poverty income ratio) and presence of
hypertension (based on the answer to a question about
whether a subject had previously been told by a doctor
they had hypertension or elevated blood pressure) on
liver markers. We also examined the interaction of alco-
hol intake (as measured by all three methods of assess-
ment) with age, gender, race/ethnicity, socioeconomic
status, and presence of hypertension. These regression
models also contained additional covariates: physical ac-
tivity (categorized as sedentary, moderate, or vigorous
based on response to questions on activity), current
smoking (yes/no), energy intake, and BMI. Significance
for all statistical comparisons was set at P < 0.01.
Results
Approximately 58.7 % of NHANES 2001–2010 adult
participants (n = 13,104) regularly consumed alcohol
(questionnaire method) and 25 % of adult participants
consumed alcohol (n = 6176) at least once over the 24-h
survey period (24-h recall method). Regardless of the
method used to identify alcohol consumers, they were
more likely to be male, younger, non-Hispanic whites,
smokers, have higher income, and have more physically-
active lifestyles compared to non-consumers.
The mean intake of alcohol as estimated by the 24-h
recall method representing the alcohol intake on the day
of recall was about 3–5 times higher than the usual in-
take estimated by NCI method or by alcohol intake
questionnaire (Table 1). Usual intake, as assessed by the
NCI method using two 24-h recalls, and intake by ques-
tionnaire representing long term intake, provided very
similar estimates of alcohol consumption.
The activities of liver enzymes of alcohol consumers
and non-consumers were compared and alcohol con-
sumers (gender combined) had significantly lower ALP
(5–6 %, P < 0.01) and higher AST (4–7 %, P < 0.01),
GGT (15–25 %, P < 0.01) and bilirubin (3 %, P < 0.01)
compared to non-consumers by both methods. However,
the difference in ALT activities of alcohol consumers
and non-consumers, were less than 3 % and were not
statistically significant (P > 0.01). To determine whether
there were dose-related differences in liver enzymes
levels in alcohol users, we examined the data by deciles
of alcohol intake (Fig. 1) as well as alcohol intake by g/
day (Fig. 2), estimated by three different methods. Table 2
provides the percentile of amount of alcohol intake by
consumers using different methods of alcohol intake es-
timation and can be used to assess the percentage of the
population consuming various levels of alcohol. Regard-
less of method used, a significant increasing linear trend
in activities of ALT, AST, and GGT, and a decreasing
linear trend in activity of ALP, was observed as alcohol
intake increased (Figs. 1 and 2, Table 3). A significant
curvilinear trend was noted for activity of ALP, AST and
GGT with some methods but not with others (Figs. 1
and 2, Table 3) indicating modification of the direction
and/or magnitude of the change as alcohol intake in-
creases. While the relationship between intake of alcohol
and activities of AST and GGT was similar in males and
females, the relationship between alcohol intake and ac-
tivities of ALP and ALT were largely driven by males
(Figs. 1 and 2, Tables 4 and 5). The increase in activity of
GGT with increase in alcohol intake was higher than the
increase in activities of ALT and AST, regardless of the
method used to measure alcohol intake (Figs. 1 and 2,
Tables 3, 4 and 5). However, no significant trends were
noted for bilirubin levels (Tables 3, 4 and 5). Dunnett
post-hoc test indicated that, based on the alcohol
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questionnaire data, we could detect a significant differ-
ence in GGT with consumption of as little as 7–14 g al-
cohol per day (P < 0.01) while differences were detected
for AST and ALT at 14–21 and 21–28 g alcohol per day,
respectively (P < 0.01).
There were significant effects of age (as age increased
ALP decreased and AST, ALP, and GGT increased), gen-
der (males were higher for all markers), and ethnicity
(the effects varied depending on the specific marker in
question) on liver markers; ALP and GGT decreased as
poverty income ratio increased and there was no effect
of hypertension status on liver markers (data not
shown). All these effects were similar regardless of
method used to assess alcohol intake. There were no sig-
nificant interactions or only a few sporadic significant
interactions (which may be due to chance given the large
number of interactions evaluated) of alcohol intake with
gender, race/ethnicity, socioeconomic status, and pres-
ence of hypertension (data not shown). However there
were significant interactions of alcohol intake for all
three measures of intake assessment with age for ALP
and GGT. For ALP there was a positive relationship of
alcohol intake up until about age 35–40 years and there-
after higher intake was associated with slightly lower
ALP. Also, GGT increased as age increased (data not
shown).
Discussion
Approximately 25 % of adults consume alcohol on a
given day as assessed by the 24-h recall method and
~60 % adults regularly consume alcohol as assessed by
the alcohol questionnaire method. Previous studies have
shown that approximately 50 % of US adults are regular
drinkers [2]. An analysis of data from NHANES 2003–
2006 using 24-h recall also found that about 33 % of
men and 17 % of women consumed some amount of an
alcoholic beverage on a given day [25]. The average
regular intake of alcohol observed in this study, as
assessed by either by questionnaire or the usual in-
take NCI method, was about 11 g/d (~16 g/d for
men and 6 g/d for women) and is considered
moderate intake by the Dietary Guidelines for Americans,
2010 definition [2].
Effects of alcohol on liver function
To the best of our knowledge, this study provides the
most current, detailed data on the association of liver
enzymes with graded levels of alcohol intake in a very
large (most likely the largest) representative sample of
the U.S. population. By combining data collected by
NHANES over the last 10 years on over 20,000 adults,
quantitative estimates of the relationship between alcohol
intake and multiple liver enzymes could be calculated with
a very high level of sensitivity to graded changes in alcohol
intake of the US population. This study demonstrates that
even very modest levels of alcohol intake can significantly
affect liver enzymes and the most sensitive measure of al-
cohol intake is the enzyme GGT which is potentiated by
alcohol intake as low as 7–14 g/day.
Our data present both linear and curvilinear (quadratic)
equations (when the latter are significant) that can be used
to assess impact of alcohol on liver enzymes. The linear
component of both sets of equations have the same direc-
tion, but the curvilinear equations have the quadratic
element which modifies the direction and/or magnitude
of change as alcohol intake increases. For example, both
the linear elements of ALP (in both linear and curvilinear
equations) are all negative, but the curvilinear component
is positive which indicates as alcohol intake increases fur-
ther the magnitude of the drop in ALP decreases. While
the linear equations are useful, when curvilinear equations
were significant these will provide a better fit of the rela-
tionship of alcohol intake with liver enzymes.
Excessive alcohol consumption can cause liver diseases
including fatty liver, hepatitis and cirrhosis [26–28].
Since alcohol is mainly metabolized by the liver, it is a
primary site of alcohol-induced adverse health effects.
Alcohol consumers had significantly higher AST and
GGT activities compared to non-consumers confirming
previous findings demonstrating that alcohol intake is as-
sociated with increased hepatic enzyme activities [12, 13].
Changes in liver enzymes activities are biomarkers of liver
Table 1 Average intake of alcohol by three different methods of estimationa, NHANES 2001–2010
Mean alcohol intake g/day Gender combined Male Female
24-h Recall N 24,807 12,561 12,246
Mean ± SE 41.0 ± 0.8 48.2 ± 1.0 29.4 ± 0.8
Usual intake by NCI method N 24,807 12,561 12,246
Mean ± SE 10.9 ± 0.2 16.1 ± 0.3 5.9 ± 0.1
Alcohol intake questionnaire N 22,307 11,376 10,931
Mean ± SE 11.0 ± 0.2 14.6 ± 0.3 6.4 ± 0.2
(N Sample Size; SE Standard Error; aAlcohol intake (g/day) was assessed three ways: 1) via a single 24-h recall; 2) by determining usual alcohol intakes with the NCI
method, an estimate of long-term intake that employed data from two days of 24-h recalls; and 3) via an alcohol intake questionnaire quantifying annual con-
sumption of alcohol)
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Fig. 1 Association of alcohol consumption by consumer deciles of intake with liver enzyme function† NHANES 2001–2010. † ALP alkaline phosphatase,
ALT alanine aminotransferase, AST aspartate aminotransferase and GGT gamma glutamyl transferase; * Significant Linear Trend at P < 0.01; # Significant
Curvilinear Trend at P < 0.01
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Fig. 2 Association of alcohol consumption by g of alcohol per day with liver enzyme function† NHANES 2001–2010. † ALP alkaline phosphatase,
ALT alanine aminotransferase, AST aspartate aminotransferase and GGT gamma glutamyl transferase; * Significant Linear Trend at P < 0.01;
#Significant Curvilinear Trend at P < 0.01; ↓Significant Dunnett at P < 0.01 continuous start point
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damage and are routinely assessed for diagnostic purposes
and as part of physical examinations [22–24]. Abnormal
activities of liver enzymes are also strong predictors of
mortality associated with liver disease, cardiovascular dis-
ease, diabetes and cancer [29–33]. However, the activities
of liver enzymes AST and GGT in alcohol consumers in
our study did not approach levels that would be consid-
ered clinically abnormal [34]. It may be possible that the
changes in the activities of liver enzyme within the normal
range are not benign and additional research is required
to determine if they are associated with subsequent devel-
opment of liver disease.
The association between alcohol consumption and
GGT has previously been demonstrated and is a widely
used index of excessive alcohol intake [12, 13, 35, 36].
Consistent with the literature, in our study serum GGT
appears to be the most sensitive measure of alcohol con-
sumption as assessed by 24-h recall, as well as alcohol
questionnaire, with respect to the difference between al-
cohol consumers and non-consumers. Our results support
previous findings that GGT is a more sensitive indicator
of moderate levels of alcohol consumption than AST and
ALT [12, 13, 16]. Elevated serum GGT has also been
shown to be associated with metabolic syndrome [37, 38]
and is considered to be the most sensitive indicator of
liver disease [39]. Previous studies have suggested the
presence of a graded dose–response relationship between
alcohol intake and risk of liver disease [40–43] and that
GGT induction can be initiated at low doses of alcohol
intake [12, 13]. In the present study we noted a gradual
increase in liver enzyme activities with increasing alcohol
dose with the largest dose-dependent increase noted for
GGT activity. This is in agreement with studies reporting
a gradual effect of increasing dose of alcohol on liver
enzyme induction [12, 13, 16].
The health effects of alcohol also vary across population
groups. A negative dose response relationship between
consumption of alcohol and prevalence of suboptimal
health was reported in a cross sectional survey from Spain
[44] while a curvilinear relationship (inverse J shaped) was
observed between alcohol intake and health related quality
of life in Dutch population [45]. Intoxication and liquor
consumption were associated with poor mental and phys-
ical health while moderate intake were associated with
better health in another cross sectional study conducted
in New York State [46]. Future studies, including epi-
demiological investigations and clinical trials, should be
conducted to investigate the relationship between intake
of various levels of alcohol, multiple health outcomes and
all-cause mortality.
The factors responsible for the beneficial effects of
moderate intake of alcohol are uncertain, although the
adverse effects of higher doses of alcohol on various
organ systems have been well documented. Increased
HDL, apolipoprtotein A-1 and adiponectin levels, and
reduction of LDL concentration, blood pressure, coronary
blood flow, platelet aggregation, fibrinogen levels and in-
flammation resulting from moderate alcohol intake have
been suggested as mechanisms that could explain the
beneficial effect of moderate alcohol intake [47, 48]. One
additional mechanism that may explain some of the bene-
ficial effects of lower doses of alcohol could be its effects
on the liver. The liver is the organ primarily responsible
for detoxifying a wide variety of metabolic and environ-
mental toxins so consumption of low doses of alcohol
could, by potentiation of key liver enzyme systems such as
Table 2 Percentiles of amount of alcohol intake by consumers estimated by three different methods of alcohol intake estimation
among adults. NHANES 2001–2010
Alcohol intake (g/day ± SE) percentiles
10th 25th 50th 75th 90th
24-h recall
All 4.52 ± 1.01 13.96 ± 0.02 28.05 ± 0.03 55.60 ± 1.56 88.50 ± 2.16
Male 10.93 ± 0.56 15.59 ± 0.85 33.48 ± 0.97 63.07 ± 2.30 102.9 ± 4.02
Female 0.74 ± 0.16 11.04 ± 0.40 21.21 ± 0.53 36.95 ± 1.21 64.71 ± 2.56
Usual intake by NCI method
All 1.84 ± 0.003 2.60 ± 0.003 5.30 ± 0.08 7.15 ± 0.49 30.20 ± 0.65
Male 3.32 ± 0.17 5.34 ± 0.01 6.70 ± 0.11 20.38 ± 0.74 42.66 ± 1.00
Female 1.38 ± 0.01 1.99 ± 0.05 2.61 ± 0.002 3.47 ± 0.002 15.94 ± 0.70
Alcohol intake questionnaire
All 0.23 ± 0.02 0.92 ± 0.002 4.00 ± 0.001 13.96 ± 0.50 27.89 ± 0.05
Male 0.44 ± 0.02 1.85 ± 0.06 7.98 ± 0.25 19.96 ± 0.28 39.42 ± 0.60
Female 0.16 ± 0.02 0.46 ± 0.001 2.00 ± 0.20 7.84 ± 0.07 15.95 ± 1.12
SE Standard Error; An alcoholic drink is defined as equals 14 g of alcohol [8, 21]
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cytochrome P450, enhance its ability to remove toxic
compounds from the body. It should be noted that levels
of GGT increase with obesity but the effects of BMI,
as well as other covariates, were adjusted for in our
analyses [49].
Methods for assessing alcohol intake
In this study we used data from 3 methods of assessing
alcohol intake, and evaluated the association of these in-
take estimates with liver enzyme functions. It is interest-
ing to note that, regardless of the method used to assess
alcohol intake, each with their own measurement error
issues, alcohol consumption significantly altered AST,
ALT & GGT. In large surveillance studies of the U.S.
population, 24-h recall is the preferred method of asses-
sing of dietary intake and determining changes in con-
sumption patterns, and these data are used in developing
regulations, policies, and dietary standards. The 24-h re-
call method provides as estimate of an individual’s alcohol
consumption on the day of recall (acute intake) but does
not capture day-to-day variation in intake and appears to
substantially overestimate annual alcohol consumption.
Table 3 Association of liver enzyme function with alcohol consumption level (Deciles and g/day) by three different methods of
alcohol intake estimation among all adults. NHANES 2001–2010a
24-h recall Usual intake by NCI method Alcohol intake questionnaire
Regression coefficientb
Alkaline phosphatase (ALP), U/L
N 21,245 21,245 19,523
By Decile Linear 47.82/−0.24* 50.70/−0.38* 48.37/−0.45*
Curvilinear 48.14/−1.10/0.11# ns ns
By g/day Linear 48.21/−0.37* 48.70/−0.45* 47.58/−0.53*
Curvilinear ns ns 51.08/−3.14/0.36#
Alanine aminotransferase (ALT), U/L
N 21,179 21,179 19,460
By Decile Linear 9.95/0.26* 7.17/0.37* 9.22/0.27*
Curvilinear ns ns ns
By g/day Linear 9.59/0.34* 8.84/0.57* 8.91/0.74*
Curvilinear ns ns ns
Aspartate aminotransferase (AST), U/L
N 21,177 21,177 19,458
By Decile Linear 18.57/0.42* 15.58/0.40* 17.06/0.33*
Curvilinear ns 17.82/−0.36/0.06# 17.75/−0.35/0.08#
By g/day Linear 18.00/0.54* 17.01/0.79* 16.64/0.93*
Curvilinear 19.28/−0.70/0.17# ns 17.86/0.02/0.12#
Gamma glutamyl transferase (GGT), U/L
N 21,245 21,245 19,523
By Decile Linear −0.64/1.65* −13.55/1.72* −5.78/1.43*
Curvilinear ns −8.30/−0.05/0.15# −3.01/−1.30/0.31#
By g/day Linear −2.94/2.21* −7.09/3.29* −7.36/3.88*
Curvilinear 2.31/−2.95/0.69# ns −3.21/0.80/0.42#
Bilirubin (mg/dl)
N 21,236 21,236 19,514
By Decile Linear 0.87/0.003* 0.86/0.001 0.84/0.005*
Curvilinear ns ns ns
By g/day Linear 0.87/0.004* 0.86/0.004 0.85/0.01*
Curvilinear ns ns ns
aRegression analyses examining linear and/or quadratic effect of alcohol intake conducted with the following covariates: age, gender, race/ethnicity, current
smoking status (yes/no), poverty income ratio, physical activity level (sedentary, moderate, or vigorous based on feedback on questions on activity), energy intake,
and body mass index. bβ0/β1 for Linear Trend and β0/β1/β2 for Curvilinear Trend (β0: intercept, β1: linear regression coefficient, and β2: curvilinear regression
coefficient); * Significant Linear Trend at P < 0.01; # Significant Curvilinear Trend at P < 0.01, N Sample Size; ns Non-significant Curvilinear Trend
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The alcohol intake questionnaire used in NHANES is de-
signed to assess long term consumption of alcohol (during
the past 12 months as well as over the lifetime) but might
not accurately represent actual alcohol intake since it re-
lies on memory and estimation of the actual amount con-
sumed by the consumer and may be difficult for subjects
to report accurately. The NCI method can estimate usual
intake distributions for episodically-consumed dietary
components like alcohol even when there are large pro-
portions of zero intakes on any given day. In this study we
found that the NCI method and the alcohol intake
questionnaire provided very similar estimates of intake
with the population means varying by only 0.1 g/d and
were predictive of multiple markers of liver function, the
biological measures of alcohol intake we examined.
Therefore, they both appear to be useful methods to
estimate alcohol intake. While various methods of al-
cohol assessment appear to be useful in assessing the
relationship with the specific physiological measures
evaluated in this study, namely liver enzymes, re-
searchers should carefully consider specific objectives
of their research and the impact of measurement
Table 4 Association of liver enzyme function with alcohol consumption level (Deciles and g/day) by three different methods of
alcohol intake estimation among male adults. NHANES 2001–2010a
24-h recall Usual intake by NCI method Alcohol intake questionnaire
Regression coefficientb
Alkaline phosphatase (ALP), U/L
N 10,858 10,858 10,025
By Decile Linear 66.64/−0.25 68.96/−0.37* 65.82/−0.29*
Curvilinear 67.25/−1.24/0.12# ns ns
By g/day Linear 67.20/−0.40* 68.07/−0.53* 65.67/−0.40
Curvilinear ns ns ns
Alanine aminotransferase (ALT), U/L
N 10,820 10,820 9987
By Decile Linear 15.08/0.36* 12.14/0.47* 14.24/0.52*
Curvilinear ns ns ns
By g/day Linear 14.46/0.45* 13.25/0.68* 13.94/0.93*
Curvilinear 16.10/−1.14/0.21# ns ns
Aspartate aminotransferase (AST), U/L
N 10,819 10,819 9986
By Decile Linear 22.45/0.48* 19.35/0.50* 21.06/0.45*
Curvilinear ns 23.03/−0.75/0.11# 21.92/−0.35/0.09#
By g/day Linear 21.66/0.57* 20.30/0.80* 20.47/0.94*
Curvilinear 23.50/−1.22/0.23# 23.07/−0.75/0.18# ns
Gamma glutamyl transferase (GGT), U/L
N 10,858 10,858 10,025
By Decile Linear 7.97/2.12* −6.88/2.38* 0.44/2.14*
Curvilinear ns 3.35/−1.07/0.30# 4.23/−1.37/0.39#
By g/day Linear 4.36/2.60* −1.90/3.66* −1.95/4.33*
Curvilinear 10.81/−3.66/0.82# ns ns
Bilirubin (mg/dl)
N 10,854 10,854 10,021
By Decile Linear 1.11/0.002 1.10/0.002 1.07/0.004
Curvilinear ns ns ns
By g/day Linear 1.11/0.003 1.11/0.002 1.07/0.01
Curvilinear ns ns ns
aRegression analyses examining linear and/or quadratic effect of alcohol intake conducted with the following covariates: age, race/ethnicity, current smoking
status (yes/no), poverty income ratio, physical activity level (sedentary, moderate, or vigorous based on feedback on questions on activity), energy intake, and
body mass index. bβ0/β1 for Linear Trend and β0/β1/β2 for Curvilinear Trend (β0: intercept, β1: linear regression coefficient, and β2: curvilinear regression
coefficient);* Significant Linear Trend at P < 0.01; # Significant Curvilinear Trend at P < 0.01; N Sample Size; ns Non-significant Curvilinear Trend
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error of the method used and study participant bur-
den to provide intake information before selecting an
alcohol assessment approach.
Study limitations and strengths
The limitations of our study include the inability to de-
termine cause-effect relationship due to cross-sectional
design of NHANES. Another limitation is the potential
for bias in self-reported intakes since alcohol intake is
often underestimated [50] and the potential for measure-
ment error of intake instruments to influence our results.
However, it should be noted that alcohol intake as esti-
mated by the questionnaire and NCI method were quite
similar and while we would expect measurement error to
attenuate our ability to detect relationships, various sig-
nificant relationship were still found. Other factors which
may impact markers of liver function (e.g., health
condition, concomitant medication use. etc.) were not
considered in these analyses and therefore residual con-
founding may have influenced our results. A major strength
of our study is the use of a large nationally representative
population-based sample of adults.
Table 5 Association of liver enzyme function with alcohol consumption level (Deciles and g/day) by three different methods of
alcohol intake estimation among female adults. NHANES 2001–2010a
24-h recall Usual intake by NCI method Alcohol intake questionnaire
Regression coefficientb
Alkaline phosphatase (ALP), U/L
N 10,387 10,387 9498
By Decile Linear 36.96/−0.21 38.96/−0.25 38.16/−0.54*
Curvilinear ns 32.91/1.73/−0.17# ns
By g/day Linear 37.31/−0.33 37.79/−0.42 37.73/−0.94*
Curvilinear ns ns 41.56/−3.92/0.46#
Alanine aminotransferase (ALT), U/L
N 10,359 10,359 9473
By Decile Linear 10.77/0.13 8.58/0.28* 10.55/0.004
Curvilinear ns ns ns
By g/day Linear 10.57/0.19 10.09/0.35 10.05/0.27
Curvilinear ns ns ns
Aspartate aminotransferase (AST), U/L
N 10,358 10,358 9472
By Decile Linear 18.10/0.34* 15.88/0.28* 16.62/0.21*
Curvilinear ns ns 17.15/−0.29/0.06#
By g/day Linear 17.58/0.50* 16.49/0.83* 15.78/0.88*
Curvilinear ns ns ns
Gamma glutamyl transferase (GGT), U/L
N 10,387 10,387 9498
By Decile Linear 0.04/0.99* −7.01/0.89* −2.16/0.67*
Curvilinear ns ns −0.44/−0.96/0.19#
By g/day Linear −1.49/1.47* −4.76/2.47* −4.73/2.77*
Curvilinear ns ns ns
Bilirubin (mg/dl)
N 10,382 10,382 9493
By Decile Linear 0.83/0.005* 0.81/0.002 0.81/0.01*
Curvilinear ns 0.86/−0.02/0.001# ns
By g/day Linear 0.82/0.01* 0.81/0.01 0.81/0.01*
Curvilinear ns 0.73/0.06/−0.01# 0.78/0.04/−0.004#
aRegression analyses examining linear and/or quadratic effect of alcohol intake conducted with the following covariates: age, race/ethnicity, current smoking
status (yes/no), poverty income ratio, physical activity level (sedentary, moderate, or vigorous based on feedback on questions on activity), energy intake, and
body mass index. bβ0/β1 for Linear Trend and β0/β1/β2 for Curvilinear Trend (β0: intercept, β1: linear regression coefficient, and β2: curvilinear regression
coefficient); * Significant Linear Trend at P < 0.01; # Significant Curvilinear Trend at P < 0.01; N Sample Size; ns Non-significant Curvilinear Trend
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Conclusions
The data presented in this study show that moderate
alcohol consumption affects liver function in a dose-
dependent manner. Use of data from the NHANES survey,
especially when combined over multiple years, provides an
opportunity to study potential adverse effects of dietary
constituents, especially those thought to be associated with
changes in biomarkers routinely assessed as part of the
NHANES survey. In addition, this study indicated usual in-
takes determined using the NCI method and an alcohol in-
take questionnaire yield similar estimates of alcohol intakes
and relationships with liver enzymes.
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